Eric Wooltorton. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » AdultAnimalsChildChild, PreschoolDermatitis, Atopic/drug therapyDermatologic Agents/adverse effectsDermatologic Agents/therapeutic useEczema/drug therapyHumansImmunosuppressive Agents/adverse effectsImmunosuppressive Agents/therapeutic useLymphoma/chemically inducedSkin Neoplasms/chemically inducedTacrolimus/adverse effectsTacrolimus/analogs & derivativesTacrolimus/therapeutic use
Substances: See more » Dermatologic AgentsImmunosuppressive AgentspimecrolimusTacrolimus
Year: 2005 PMID: 15817641 PMCID: PMC557066 DOI: 10.1503/cmaj.050373
Source DB: PubMed Journal: CMAJ ISSN: 0820-3946 Impact factor: 8.262